Cancer Research News: January 3 – January 17

In the Economist, Dr. Ron Depinho, the new president of the M.D. Anderson Cancer Center, shares his plans for curing cancers.
A genetic study explains chemoresistance in some colorectal cancer patients.
Women who take antiestrogen supplements may decrease their risk for melanoma.
Navitoclax, a new drug in phase I trials, has had impressive results against hard-to-treat Chronic Lymphocytic Leukemia.

Cancer Research News: December 21 – January 3

An interview with Dr. Harold Varmus marks the 40th anniversary of the National Cancer Act.
The carcinogenic role of HPV in lung cancer is being studied in France.
ATM gene mutations increase risk for hereditary pancreatic cancer.
Emory University researchers study cancer cells’ need for glucose.
Ohio State study demonstrates how normal cells can promote tumor growth after loss of the tumor suppressor gene Pten.

A study of two sisters provides new insight into lymphoma development.
The New Mexico’s Women’s Health Study provides evidence that breast cancer mortality is higher in Hispanic women.
The Institute of Medicine issued a report on environmental factors and the risk of breast cancer.
The National Human Genome Research Institute (NHGRI) released a new funding plan that includes a gradual reduction in the base funding for the large-scale sequencing centers.
A potential blood test for colorectal cancer has been developed by ARUP Laboratories.